Related Experiment Video

Updated: Jun 19, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Uniquely modified RNA oligonucleotides targeting STAT3 suppress melanoma growth both in vitro and in vivo

Lifang Yang1, Xiaoqian Ma, Lanbo Xiao

  • 1Cancer Research Institute, Xiangya School of Medicine, Central South University, Changsha, Hunan, P.R. China.

Cancer Biology & Therapy
|October 14, 2009
PubMed

Insights

Novel modified RNA oligonucleotides targeting Signal Transducers and Activators of Transcription-3 (STAT3) effectively inhibited melanoma cell growth and tumor development. This approach shows promise for studying STAT3 in melanoma and as a potential anti-cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • RNA Therapeutics

Background:

  • Signal transducers and activators of transcription-3 (STAT3) is a key transcription factor often overexpressed in malignant cells.
  • STAT3 overexpression is implicated in melanoma tumorigenesis and progression.

Purpose of the Study:

  • To develop and evaluate novel, modified antisense RNA oligonucleotides targeting STAT3 mRNA for melanoma treatment.
  • To assess the efficacy of these oligonucleotides in inhibiting melanoma cell growth and tumor xenografts.

Main Methods:

  • Design of 2'-O-methyl modified RNA oligonucleotides with a 3'-butanol tag targeting STAT3 mRNA.
  • In vitro assessment of inhibition of STAT3 gene expression, cell apoptosis, and proliferation in melanoma cells.
  • In vivo evaluation of tumor xenograft growth inhibition in nude mice.

Main Results:

  • The modified RNA oligonucleotides (STT-33 and STT-34) demonstrated enhanced stability.
  • Significant inhibition of STAT3 gene expression, increased apoptosis, and reduced proliferation in melanoma cells.
  • Substantial inhibition of melanoma xenograft growth in vivo.

Conclusions:

  • Novel modified RNA oligonucleotides targeting STAT3 are effective in inhibiting melanoma progression.
  • These agents represent a promising tool for investigating STAT3's role in melanoma and as potential anti-cancer therapeutics.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...